Biotech Specialty Pharma

Porsolt & Partners Pharmacology

9 bis, rue Henri Martin
Boulogne-Bilancourt, 92100 France
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Drug efficacy and safety evaluation in animal pharmacology.

Management Roger D. Porsolt, Ph.D., President and Chief Executive Officer; Pierre Lacroix, Ph.D., Scientific Director; Martine Lemaire, Pharm.D., Ph.D., Senior Director, Scientific & Business Development; Paul Moser, Ph.D., Head of CNS Pharmacology; Sandra Picard, Ph.D., Head of Cardiovascular & General Pharmacology; Richard Chevreuse, Senior Director, Finance and Administration

Click here for Financial Data
Keywords: drug efficacy, drug safety, animal pharmacology, CNS, inflammation, cardiovascular, respiratory, renal


Updated: Feb. 03, 2009


Porsolt & Partners Pharmacology is an independent Contract Research Organisation (CRO) engaged in animal pharmacology.......view more

Products / Services

Porsolt & Partners Pharmacology provides services in two core areas: drug efficacy and safety evaluation. Porsolt & Partners has expertise in a wide range of therapeutic research areas, including CNS,......view more